| Literature DB >> 17245541 |
Joanne Kotsopoulos1, Jan Lubinski, Henry T Lynch, Jan Klijn, Parviz Ghadirian, Susan L Neuhausen, Charmaine Kim-Sing, William D Foulkes, Pal Moller, Claudine Isaacs, Susan Domchek, Susan Randall, Kenneth Offit, Nadine Tung, Peter Ainsworth, Ruth Gershoni-Baruch, Andrea Eisen, Mary Daly, Beth Karlan, Howard M Saal, Fergus Couch, Barbara Pasini, Teresa Wagner, Eitan Friedman, Gad Rennert, Charis Eng, Jeffrey Weitzel, Ping Sun, Steven A Narod, J Garber, M Osborne, D Fishman, J McLennan, W McKinnon, S Merajver, H Olsson, D Provencher, B Pasche, G Evans, W S Meschino, E Lemire, A Chudley, D Rayson, C Bellati.
Abstract
An early age at first full-term birth is associated with a reduction in the subsequent development of breast cancer among women in the general population. A similar effect has not yet been reported among women who carry an inherited BRCA1 or BRCA2 mutation. We conducted a matched case-control study on 1816 pairs of women with a BRCA1 (n = 1405) or BRCA2 (n = 411) mutation in an attempt to elucidate the relationship between age at first full-term pregnancy and the risk of developing breast cancer. Information about the age at first childbirth and other pregnancy-related variables was derived from a questionnaire administered to women during the course of genetic counselling. There was no difference in the mean age at first full-term birth in the cases and controls (24.9 years vs. 24.8 years; P = 0.81, respectively). Compared to women whose first child was born at or before 18 years of age, a later age at first full-term birth did not influence the risk of developing breast cancer (OR = 1.00 per year; 95% CI 0.98-1.03; P-trend = 0.67). Stratification by mutation status did not affect the results. These findings suggest that an early first full-term birth does not confer protection against breast cancer in BRCA mutation carriers. Nonetheless, BRCA mutation carriers opting for a prophylactic oophorectomy as a breast and/or ovarian cancer risk-reducing strategy should complete childbearing prior to age 40 when this prevention modality is most effective.Entities:
Mesh:
Year: 2007 PMID: 17245541 DOI: 10.1007/s10549-006-9441-3
Source DB: PubMed Journal: Breast Cancer Res Treat ISSN: 0167-6806 Impact factor: 4.872